Oncology Bulletin - 9 October 2023

Editor's pick of the week

What advancements have been made in understanding breast cancer risk?

A recent Collection from the National Institute for Health and Care Research (NIHR) brings together a range of resources on our current understanding of individual risk factors for breast cancer and makes recommendations for national screening programs in the UK. Find out more here >>>.

Latest articles

Tackling disparities in cancer care across Europe: how can we improve access for all patients in Europe?

Across Europe there are significant disparities in access to cancer care. Access to new medicines varies from 4 months to almost 2 years post-market authorization across countries and regions. In this opinion piece, Gerwin Winter (BeiGene, Basel, Switzerland) and Eric Low (ELC, UK) discuss potential innovative solutions to address these disparities.

Developing a urine test for detecting prostate cancer: an interview with Sanoj Punnen

Sanoj Punnen (University of Miami, CA, USA) is leading a study to develop a urine test to detect prostate cancer. The research could help lessen the need for invasive, costly prostate biopsies. In this interview we provide you with a bitesize breakdown of key points of the research.

Looking to the future of immunotherapy in cancer treatment

Millions of people with cancer already benefit from immunotherapy, but there is always more we can do to develop transformative treatments. Find out about patient-focused solutions, such as immune-cell engagers and next-generation cell therapies in our latest opinion article.